Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is the BNT162b2 vaccine still effective against the latest variant: XBB.1.5?

Nigerian journal of clinical practice - 1 Oct 2023

Erdag Emine, Sultanoglu Nazife, Ozverel Cenk S

Abstract excerpt

Background: The XBB.1.5 sub-variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron now continues to spread rapidly due to the increased transmission rate as a result of increased affinity of the virus binding over the ACE-2 receptor - a gained property due to the mutation that occurred in spike protein. Aim: The protectivity of BNT162b2 antibodies produced in the serum of patients is an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Mutation
Share to SARS-CoV-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Spike Glycoprotein, Coronavirus

Source

Identifiers

PMID: 37929529
DOI: 10.4103/njcp.njcp_208_23

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is the BNT162b2 vaccine still effective against the latest variant: XBB.1.5?PMID 37929529Read ↗

XBB .1.5 neutralizing antibodies upon bivalent COVID ‐19 vaccination are similar to XBB but lower than BQ .1.1Semantic proximity Read ↗

SARS-CoV-2 Omicron BA.2.86: less neutralization evasion compared to XBB sub-variantsSemantic proximity Read ↗

Preclinical Characterization of the Omicron XBB.1.5-Adapted BNT162b2 COVID-19 VaccineSemantic proximity Read ↗

SARS-CoV-2 Spike Protein XBB.1.5 Mutations Altered Four Conserved Antigenic Determinants.Semantic proximity Read ↗

The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteinsSemantic proximity Read ↗

Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulations.Semantic proximity Read ↗

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionSemantic proximity Read ↗

A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2Semantic proximity Read ↗

The Omicron XBB.1 Variant and its Descendants: Genomic Mutations, Rapid Dissemination and Notable CharacteristicsSemantic proximity Read ↗

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariantsSemantic proximity Read ↗

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1Semantic proximity Read ↗

Continued evasion of neutralizing antibody response by Omicron XBB.1.16Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.